The Contribution of Immune Regulatory and Thyroid Specific Genes to the Etiology of Graves' and Hashimoto's Diseases

References

• Davies, T.F. (2000) "Graves' diseases: pathogenesis", In: Braverman, L.E. and Utiger, RD., eds, Werner, and Ingbar's The Thyroid: A Fundamental and Clinical Text (Lippincott Williams and Wilkens, Philadelphia), pp 518–530.
   Google Scholar
• Weetman, AR (1996) "Chronic autoimmune thyroiditis", In: Braverman, L.E. and Utiger, RD., eds, Werner and Ingbar's The Thyroid (Lippincott-Raven, Philadelphia), pp 738–748.
   Google Scholar
• Brix, T.H., Kyvik, K.O. and Hegedus, L. (1998) "What is the evidence of genetic factors in the etiology of Graves' disease? A brief review", Thyroid 8, 727–734.
   PubMed Web of Science ®Google Scholar
• Tomer, Y., Barbesino, G., Greenberg, D.A. and Davies, T.F. (1997) "The immunogenetics of autoimmune diabetes and autoimmune thyroid disease", Trends Endocrinol. Metab. 8, 63–70.
   PubMed Web of Science ®Google Scholar
• Bartels, ED. (1941) Twin Examinations: Heredity in Graves' Disease (Munksgaad, Copenhagen), pp 32–36.
   Google Scholar
• Martin, L. (1945) "The heredity and familial aspects of exophathalmic goitre and nodular goitre", Q. J. Med. 14, 207–219.
   PubMedGoogle Scholar
• Hall, R. and Stanbury, J.B. (1967) "Familial studies of autoimmune thyroiditis", Clin. Exp. Immunol. 2, 719–725.
   Google Scholar
• Villanueva, R.B., Inzerillo, A.M., Tomer, Y, Barbesino, G., Meltzer, M., Concepcion, ES., Greenberg, D.A., Maclaren, N., Sun, Z.S., Zhang, D.M., Tucci, S. and Davies, T.F. (2000) "Limited genetic susceptibility to severe Graves' ophthalmopathy: no role for CTLA-4 and evidence for an environmental etiology", Thyroid 10, 791–798.
   PubMed Web of Science ®Google Scholar
• Risch, N. (1990) "Linkage strategies for genetically complex traits. IL The power of affected relative pairs", Am. J. Hum. Genet. 46, 229–241.
   PubMed Web of Science ®Google Scholar
• Vyse, T.J. and Todd, J.A. (1996) "Genetic analysis of autoimmune disease", Cell 85, 311–318.
   PubMed Web of Science ®Google Scholar
• Brix, T.H., Christensen, K., Holm, NV., Harvald, B. and Hegedus, L. (1998) "A population-based study of Graves' diseases in Danish twins", Clin. Endocrinol. 48, 397–400.
   PubMed Web of Science ®Google Scholar
• Brix, T.H., Kyvik, K.O., Christensen, K. and Hegedus, L. (2001) "Evidence for a major role of heredity in Graves' disease: a population-based study of two Danish twin cohorts", J. Clin. Endocrinol. Metab. 86, 930–934.
   PubMed Web of Science ®Google Scholar
• Ringold, D.A., Nicoloff, J.T., Kesler, M., Davis, H., Hamilton, A. and Mack, T. (2002) "Further evidence for a strong genetic influence on the development of autoimmune thyroid disease: the California twin study", Thyroid 12, 647–653.
   PubMed Web of Science ®Google Scholar
• Brix, T.H., Kyvik, K.O. and Hegedus, L. (2000) "A population-based study of chronic autoimmune hypothyroidism in Danish twins", J. Clin. Endocrinol. Metab. 85, 536–539.
   PubMed Web of Science ®Google Scholar
• Phillips, DI, Osmond, C., Baird, J., Huckle, A. and Rees-Smith, B. (2002) "Is birthweight associated with thyroid autoimmunity? A study in twins", Thyroid 12, 377–380.
   PubMed Web of Science ®Google Scholar
• Todd, J.A., Acha-Orbea, H., Bell, J.I., Chao, N., Fronek, Z., Jacob, C.O., McDermott, M., Sinha, A.A., Timmerman, L., Steinman, L, et al. (1988) "A molecular basis for MHC class 1I-associated autoimmunity", Science 240, 1003–1009.
   PubMed Web of Science ®Google Scholar
• Bech, K., Lumholtz, B., Nerup, J., Thomsen, M., Platz, P., Ryder, L.P., Svejgaard, A., Siersbaek-Nielsen, K., Hansen, J.M. and Larse, J.H. (1977) "HLA antigens in Graves' disease", Acta Endocrinol. 86, 510–516.
   PubMedGoogle Scholar
• Farid, N.R., Stone, E. and Johnson, G. (1980) "Graves' disease and HLA: clinical and epidemiologic associations", Clin. Endocrinol. (Oxf) 13, 535–544.
   PubMed Web of Science ®Google Scholar
• Farid, N.R. (1981) "Graves' disease", In: Farid, N.R., ed, HLA in Endocrine and Metabolic Disorders (Academic Press, New York), pp 85–143.
   Google Scholar
• Farid, N.R., Sampson, L., Noel, ER, Barnard, J.M., Mandeville, R., Larsen, B., Marshall, W.H. and Carter, N.D. (1979) "A study of human D locus related antigens in Graves' disease", J. Clin. Investig. 63, 108–113.
   PubMed Web of Science ®Google Scholar
• Mangklabruks, A., Cox, N. and DeGroot, L.J. (1991) "Genetic factors in autoimmune thyroid disease analyzed by restriction fragment length polymorphisms of candidate genes", J. Clin. Endocrinol. Metab. 73, 236–244.
   PubMed Web of Science ®Google Scholar
• Volpe, R. (1990) "Immunology of human thyroid disease", In: Volpe, R., ed, Autoimmunity in Endocrine Disease (CRC Press, Boca Raton), p 73.
   Google Scholar
• Heward, J.M., Allahabadia, A., Daykin, J., Carr-Smith, J., Daly, A., Armitage, M., Dodson, P.M., Sheppard, MC., Barnett, A.H., Franklyn, J.A. and Gough, S.C. (1998) "Linkage disequilibrium between the human leukocyte antigen class 11 region of the major histocompatibility complex and Graves' disease: replication using a population case control and family-based study", J. Clin. Endocrinol. Metab. 83, 3394–3397.
   PubMed Web of Science ®Google Scholar
• Barlow, A.B.T., Wheatcroft, N., Watson, P. and Weetman, AR (1996) "Association of HLA-DQA1*0501 with Graves' disease in English Caucasian men and women", Clin. Endocrinol. 44, 73–77.
   PubMed Web of Science ®Google Scholar
• Yanagawa, T., Mangklabruks, A., Chang, Y.B., Okamoto, Y, Fisfalen, M-E., Curran, P.G. and DeGroot, L.J. (1993) "Human histocompatibility leukocyte antigen-DQA1*0501 allele associ-ated with genetic susceptibility to Graves' disease in a Caucasian population", J. Clin. Endocrinol. Metab. 76, 1569–1574.
   PubMed Web of Science ®Google Scholar
• Marga, M., Denisova, A., Sochnev, A., Pirags, V. and Farid, N.R. (2001) "Two HLA DRB 1 alleles confer independent genetic susceptibility to Graves disease: relevance of cross-population studies", Am. J. Med. Genet. 102, 188–191.
   PubMed Web of Science ®Google Scholar
• Zamani, M., Spaepen, M., Bex, M., Bouillon, R. and Cassiman, J.J. (2000) "Primary role of the HLA class 11 DRB1*0301 allele in Graves disease", Am. J. Med. Genet. 95, 432–437.
   PubMed Web of Science ®Google Scholar
• Marsh, S.G., Bodmer, J.G., Albert, E.D., Bodmer, W.F., Bontrop, R.E., Dupont, B., Erlich, H.A., Hansen, J.A., Mach, B., Mayr, W.R., Parham, R, Petersdorf, E.W., Sasazuld, T., Schreuder, G.M., Strominger, J.L., Svejgaard, A. and Terasaki, RI. (2001) "Nomenclature for factors of the HLA system, 2000", Hum. Immunol. 62, 419–468.
   PubMedGoogle Scholar
• Ban, Y, Davies, T.F., Greenberg, D.A., Concepcion, ES. and Tomer, Y. (2002) "Potential role of HLA-DR-74 Arginine in the genetic susceptibility to Graves' disease". The 84th Annual Meeting of the Endocrine Society, San Francisco, CA.
   Google Scholar
• Segni, M., Path, M.A., Pasquino, A.M. and Badenhoop, K. (2002) "Familial clustering of juvenile thyroid autoimmunity: higher risk is conferred by human leukocyte antigen DR3-DQ2 and thyroid peroxidase antibody status in fathers", J. Clin. Endocrinol. Metab. 87, 3779–3782.
   PubMed Web of Science ®Google Scholar
• Schleusener, H., Schwander, J., Fischer, C., Holle, R., Holl, G., Badenhoop, K., Hensen, J., Finke, R., Bogner, U. and Mayr, W.R. (1989) "Prospective multicentre study on the prediction of relapse after antithyroid drug treatment in patients with Graves' disease", Acta Endocrinol. (Copenh.) 120, 689–701.
   PubMedGoogle Scholar
• Dahlberg, P.A., Holmlund, G., Karlsson, F.A. and Safwenberg, J. (1981) "HLA-A, -B, -C and -DR antigens in patients with Graves' disease and their correlation with signs and clinical course", Acta Endocrinol. (Copenh.) 97, 42–47.
   PubMedGoogle Scholar
• McKenna, R., Kearns, M., Sugrue, D., Drury, MI and McCarthy, C.F. (1982) "HLA and hyperthyroidism in Ireland", Tissue Antigens 19, 97–99.
   PubMedGoogle Scholar
• Allannic, H., Fauchet, R., Lorcy, Y, Gueguen, M., Le Guerrier, A.M. and Genetet, B. (1983) "A prospective study of the relationship between relapse of hyperthyroid Graves' disease after antithyroid drugs and HLA haplotype", J. Clin. Endocrinol. Metal,. 57, 719–722.
   PubMed Web of Science ®Google Scholar
• Kendall-Taylor, R, Stephenson, A., Stratton, A., Papiha, S.S., Perros, P. and Roberts, D.F. (1988) "Differentiation of auto-immune ophthalmopathy from Graves' hyperthyroidism by analysis of genetic markers", Clin Endocrinol. (Oxf) 28, 601–610.
   PubMed Web of Science ®Google Scholar
• Rapoport, B., Alsabeh, R., Aftergood, D. and McLachlan, S.M. (2000) "Elephantiasic pretibial myxedema: insight into and a hypothesis regarding the pathogenesis of the extrathyroidal manifestations of Graves' disease", Thyroid 10, 685–692.
   PubMed Web of Science ®Google Scholar
• Irvine, W.J., Gray, R.S., Morris, P.J. and Ting, A. (1978) "HLA in primary atrophic hypothyroidism and Hashimoto goitre", J. Clin. Lab Immunol. 3, 193–195.
   Google Scholar
• Farid, N.R., Sampson, L., Moens, H. and Barnard, J.M. (1981) "The association of goitrous autoimmune thyroiditis with HLA-DR5", Tissue Antigens 17, 265–268.
   PubMedGoogle Scholar
• Moens, H., Farid, N.R., Sampson, L., Noel, E.P. and Barnard, J.M. (1978) "Hashimoto's thyroiditis is associated with HLA-DRw3", N. EngL J. Med. 299, 133–134.
   PubMed Web of Science ®Google Scholar
• Tandon, N., Zhang, L. and Weetman, A.P. (1991) "HLA associations with Hashimoto's thyroiditis", Clin. Endocrinol. (Oxf) 34, 383–386.
   PubMed Web of Science ®Google Scholar
• Ban, Y, Davies, T.F., Greenberg, D.A., Concepcion, ES. and Tomer, Y. (2002) "The influence of human leucocyte antigen (HLA) genes on autoimmune thyroid disease (AITD): results of studies in HLA-DR3 positive AITD families", Clin. Endocrinol. (Oxf) 57, 81–88.
   PubMed Web of Science ®Google Scholar
• Kong, Y.C., Lomo, L.C., Mate, R.W., Giraldo, A.A., Baisch, J., Strauss, G., Hammerling, G.J. and David, C.S. (1996) "IiLA-DRB1 polymorphism determines susceptibility to auto-immune thyroiditis in transgenic mice: definitive association with HLA-DRB1*0301 (DR3) gene", J. Exp. Med. 184, 1167–1172.
   PubMed Web of Science ®Google Scholar
• Wu, Z., Stephens, H.A.F., Sachs, LA., Biro, RA., Cutbush, S., Magzoub, MM., Becker, C., Schwartz, G. and Botazzo, G.F. (1994) "Molecular analysis of HLA-DQ and -DP genes in caucasoid patients with Hashimoto's thyroiditis", Tissue Antigens 43, 116–119.
   PubMedGoogle Scholar
• Badenhoop, K., Schwartz, G., Walfish, P.G., Drummond, V., Usadel, KR and Bottazzo, G.F. (1990) "Susceptibility to thyroid autoimmune disease: molecular analysis of HLA-D region genes identifies new markers for goitrous Hashimoto's thyroiditis", J. Clin. Endocrinol. Metab. 71, 1131–1137.
   PubMed Web of Science ®Google Scholar
• Bode, H.H., Dorf, M.E. and Forbes, A.P. (1973) "Familial lymphocytic thyroiditis: analysis of linkage with histocompati-bility and blood group", J. Clin. Endocrinol. Metab. 37, 692–697.
   PubMed Web of Science ®Google Scholar
• Roman, S.H., Greenberg, D.A., Rubinstein, P., Wallenstein, S. and Davies, T.F. (1992) "Genetics of autoimmune thyroid disease: lack of evidence for linkage to HLA within families", J. Clin. Endocrinol. Metab. 74, 496–503.
   PubMed Web of Science ®Google Scholar
• Barbesino, G., Tomer, Y, Concepcion, ES., Davies, T.F. and Greenberg, D.A. (1998) "Linkage analysis of candidate genes in autoimmune thyroid disease: I. Selected inununoregulatory genes", J. Clin. Endocrinol. Metab. 83, 1580–1584.
   PubMed Web of Science ®Google Scholar
• Vaidya, B., Imrie, H., Perros, P., Young, E.T., Kelly, W.F., Can, D., Large, D.M., Toft, A.D., McCarthy, MI, Kendall-Taylor, P. and Pearce, S.H. (1999) "The cytotoxic T lymphocyte antigen-4 is a major Graves' disease locus", Hum. Mol. Genet. 8, 1195–1199.
   PubMed Web of Science ®Google Scholar
• Shields, D.C., Ratanachaiyavong, S., McGregor, A.M., Collins, A. and Morton, N.E. (1994) "Combined segregation and linkage analysis of Graves' disease with a thyroid autoantibody diathesis", Am. J. Hum. Genet. 55, 540–554.
   PubMed Web of Science ®Google Scholar
• Reiser, H. and Stadecker, M.J. (1996) "Costimulatory B7 molecules in the pathogenesis of infectious and autoimmune diseases", N. Engl. J. Med. 335, 1369–1377.
   PubMed Web of Science ®Google Scholar
• Hutloff, A., Dittrich, A.M., Beier, K.C., Eljaschewitsch, B., Kraft, R., Anagnostopoulos, I. and Kroczek, R.A. (1999) "ICOS is an inducible T-cell co-stimulator structurally and functionally related to CD28", Nature 397, 263–266.
   PubMed Web of Science ®Google Scholar
• Coyle, A.J., Lehar, S., Lloyd, C., Tian, J., Delaney, T., Manning, S., Nguyen, T., Burwell, T., Schneider, H., Gonzalo, J.A., Gosselin, M., Owen, L.R., Rudd, C.E. and Gutierrez-Ramos, J.C. (2000) "The CD28-related molecule ICOS is required for effective T cell-dependent immune responses", Immunity 13, 95–105.
   PubMed Web of Science ®Google Scholar
• Yanagawa, T., Hidaka, Y, Guimaraes, V., Soliman, M. and DeGroot, L.J. (1995) "CTLA-4 gene polymorphism associated with Graves' disease in a Caucasian population", J. Clin. Endocrinol. Metab. 80, 41–45.
   PubMed Web of Science ®Google Scholar
• Nistico, L., Buzzetti, R., Pritchard, L.E., Van der Auwera, B., Giovannini, C., Bosi, E., Larrad, KT., Rios, MS., Chow, C.C., Cockram, CS., Jacobs, K., Mijovic, C., Bain, S.C., Barnett, A.H., Vandewalle, C.L., Schuit, F., Gorus, F.K., Tosi, R., Pozzilli, P. and Todd, J.A. (1996) "The CTLA-4 gene region of chromosome 2q33 is linked to, and associated with, type 1 diabetes. The Belgian Diabetes Registry", Hum. Mol. Genet. 5, 1075–1080.
   PubMed Web of Science ®Google Scholar
• Donner, H., Rau, H., Walfish, P.G., Braun, J., Siegmund, T., Finke, R., Herwig, J., Usadel, K.H. and Badenhoop, K. (1997) "CTLA4 alanine-17 confers genetic susceptibility to Graves' disease and to type 1 diabetes mellitus", J. Clin. Endocrinol. Metab. 82, 143–146.
   PubMed Web of Science ®Google Scholar
• Kotsa, K., Watson, P.F. and Weetman, A.P. (1997) "A CTLA-4 gene polymorphism is associated with both Graves' disease and autoimmune hypothyroidism", Clin. Endocrinol. 46, 551–554.
   PubMed Web of Science ®Google Scholar
• Kould, T., Gardine, C.A., Yanagawa, T. and DeGroot, L.J. (2002) "Relation of three polymorphisms of the CTLA-4 gene in patients with Graves' disease", J. Endocrinol. Investig. 25, 208–213.
   PubMed Web of Science ®Google Scholar
• Nithiyananthan, R., Heward, J.M., Allahabadia, A., Franklyn, J.A. and Gough, S.C. (2002) "Polymorphism of the CTLA-4 gene is associated with autoimmune hypothyroidism in the United Kingdom", Thyroid 12, 3–6.
   PubMed Web of Science ®Google Scholar
• Braun, J., Donner, H., Siegmund, T., Walfish, P.G., Usadel, K.H. and Badenhoop, K. (1998) "CTLA-4 promoter variants in patients with Graves' disease and Hashimoto's thyroiditis", Tissue Antigens 51, 563–566.
   PubMedGoogle Scholar
• Yanagawa, T., Taniyama, M., Enomoto, S., Gomi, K., Maruyama, H., Ban, Y. and Sanita, T. (1997) "CTLA4 gene polymorphism confers susceptibility to Graves' disease in Japanese", Thyroid 7, 843–846.
   PubMed Web of Science ®Google Scholar
• Heward, J.M., Allahabadia, A., Armitage, M., Hattersley, A., Dodson, P.M., Macleod, K., Can-Smith, J., Daykin, J., Daly, A., Sheppard, M.C., Holder, R.L., Barnett, A.H., Franklyn, J.A. and Gough, S.C. (1999) "The development of Graves' disease and the CTLA-4 gene on chromosome 2q33", J. Clin. Endocrinol. Metab. 84, 2398–2401.
   PubMed Web of Science ®Google Scholar
• Heward, J.M., Allahabadia, A., Can-Smith, J., Daykin, J., Cockram, CS., Gordon, C.B.A.H., Franklyn, J.A. and Gough, S.C.L. (1998) "No evidence for allelic association of human CTLA-4 promoter polymorphism with autoimmune thyroid disease in either population-based case-control or family-based studies", Clin. Endocrinol. 49, 331–334.
   Google Scholar
• Donner, H., Braun, J., Seidl, C., Rau, H., Finke, R., Ventz, M., Walfish, P.G., Usadel, K.H. and Badenhoop, K. (1997) "Codon 17 polymorphism of the cytotoxic T lymphocyte antigen 4 gene in Hashimoto's thyroiditis and Addison's disease", J. Clin. Endo-crinol. Metab. 82, 4130–4132.
   PubMed Web of Science ®Google Scholar
• Petrone, A., Giorgi, G., Mesturino, C.A., Capizzi, M., Cascino, I., Nistico, L., Osborn, J., Di Mario, U. and Buzzetti, R. (2001) "Association of DRB1*04-DQB1*0301 haplotype and lack of association of two polymorphic sites at CTLA-4 gene with Hashimoto's thyroiditis in an Italian population", Thyroid 11, 171–175.
   PubMed Web of Science ®Google Scholar
• Tomer, Y. (2001) "Unraveling the genetic susceptibility to autoimmune thyroid diseases: CTLA-4 takes the stage", Thyroid 11, 167–169.
   PubMed Web of Science ®Google Scholar
• Marron, M.P., Raffel, L.J., Garchon, H.J., Jacob, C.O., SerranoRios, M., Martinez Larrad, M.T., Teng, W.P., Park, Y, Zhang, Z.X., Goldstein, D.R., Tao, Y.W., Beaurain, G., Bach, J.F., Huang, H.S., Luo, D.F., Zeidler, A., Rotter, J.I., Yang, M.C.K., Modilevsky, T., Maclaren, N.K. and She, J.X. (1997) "Insulin-dependent diabetes mellitus (1DDM) is associated with CTLA4 polymorphisms in multiple ethnic groups", Hum. Mol. Genet. 6, 1275–1282.
   PubMed Web of Science ®Google Scholar
• Vaidya, B., Imrie, H., Geatch, D.R., Perros, P., Ball, S.G., Baylis, P.H., Carr, D., Hurel, S.J., James, R.A., Kelly, WE, Kemp, E.H., Young, E.T., Weetman, A.P., Kendall-Taylor, P. and Pearce, S.H. (2000) "Association analysis of the cytotoxic T lymphocyte antigen-4 (CTLA-4) and autoimmune regulator-1 (AIRE-1) genes in sporadic autoimmune Addison's disease", J. Clin. Endocrinol. Metab. 85, 688–691.
   PubMed Web of Science ®Google Scholar
• Huang, D., Liu, L., Noren, K., Xia, SQ., Trifunovic, J., Pirskanen, R. and Lefvert, A.K. (1998) "Genetic association of Ctla-4 to myasthenia gravis with thymoma", J. NeuroimmunoL 88, 192–198.
   PubMed Web of Science ®Google Scholar
• Tomer, Y, Greenberg, D.A., Barbesino, G., Concepcion, ES. and Davies, T.F. (2001) "CTLA-4 and not CD28 is a susceptibility gene for thyroid autoantibody production", J. Clin. Endocrinol. Metab. 86, 1687–1693.
   PubMed Web of Science ®Google Scholar
• Zaletel, K., Krhin, B., Gaberscek, S., Pirnat, E. and Hojker, S. (2002) "The influence of the exon 1 polymorphism of the cytotoxic T lymphocyte antigen 4 gene on thyroid antibody production in patients with newly diagnosed Graves' disease", Thyroid 12, 373–376.
   PubMed Web of Science ®Google Scholar
• Vanderpump, M.P.J., Tunbridge, W.M.G., French, J.M., Appleton, D., Bates, D., Clark, F., Grimley Evans, J., Hasan, D.M., Rodgers, H., Tunbridge, F. and Young, E.T. (1995) "The incidence of thyroid disorders in the community: a twenty-year follow-up of the Whickham survey", Clin. Endocrinol. (Oxf.) 43, 55–68.
   PubMed Web of Science ®Google Scholar
• Park, Y.J., Chung, H.K., Park, D.J., Kim, W.B., Kim, S.W., Koh, J.J. and Cho, B.Y. (2000) "Polymorphism in the promoter and exon 1 of the cytotoxic T lymphocyte antigen-4 gene associated with autoimmune thyroid disease in Koreans", Thyroid 10, 453–459.
   PubMed Web of Science ®Google Scholar
• Yung, E., Cheng, P.S., Fok, T.F. and Wong, G.W. (2002) "CTLA-4 gene A-G polymorphism and childhood Graves' disease", Clin. Endocrinol. (Oxf ) 56, 649–653.
   PubMed Web of Science ®Google Scholar
• Allahabadia, A., Heward, J.M., Nithiyananthan, R., Gibson, S.M., Reuser, T.T., Dodson, P.M., Franklyn, J.A. and Gough, S.C. (2001) "MHC class II region, CTLA4 gene, and ophthalmopathy in patients with Graves' disease", Lancet 358, 984–985.
   PubMed Web of Science ®Google Scholar
• Vaidya, B., Imrie, H., Perros, P., Dickinson, J., McCarthy, AIL Kendall-Taylor, P. and Pearce, S.H. (1999) "Cytotoxic T lymphocyte antigen-4 (CTLA-4) gene polymorphism confers susceptibility to thyroid associated orbitopathy [letter]", Lancet 354, 743–744.
   PubMed Web of Science ®Google Scholar
• Marron, M.P., Zeidler, A., Raffel, L.J., Eckenrode, SE., Yang, J.J., Hopkins, DJ., Garchon, H.J., Jacob, C.O., Serrano-Rios, M., Martinez Larrad, UT., Park, Y., Bach, J.F., Rotter, J.I., Yang, MC. and She, J.X. (2000) "Genetic and physical mapping of a type 1 diabetes susceptibility gene (1DDM12) to a 100-kb phagemid artificial chromosome clone containing D2S72-CTLA4-D2S105 on chromosome 2q33", Diabetes 49, 492–499.
   Google Scholar
• Wood, J.P., Pani, MA., Bieda, K., Meyer, G., Usadel, K.H. and Badenhoop, K. (2002) "A recently described polymorphism in the CD28 gene on chromosome 2q33 is not associated with susceptibility to type 1 diabetes", Eur. J. Immunogenet. 29, 347–349.
   PubMedGoogle Scholar
• Tomer, Y., Barbesino, G., Greenberg, D.A., Concepcion, E.S. and Davies, T.F. (1998) "A new Graves disease-susceptibility locus maps to chromosome 20q11.2", Am. J. Hum. Genet. 63, 1749–1756.
   PubMed Web of Science ®Google Scholar
• Pearce, S.H., Vaidya, B., Imrie, H., Perros, P., Kelly, WE, Toft, AD., McCarthy, ML, Young, E.T. and Kendall-Taylor, P. (1999) "Further evidence for a susceptibility locus on chromosome 20q13.11 in families with dominant transmission of Graves disease [letter]", Am. J. Hum. Genet. 65, 1462–1465.
   PubMed Web of Science ®Google Scholar
• Dune, F.H., Foy, TM., Masters, SR., Laman, J.D. and Noelle, R.J. (1994) "The role of CD40 in the regulation of humoral and cell-mediated immunity", ImmunoL Today 15,406–411.
   PubMedGoogle Scholar
• Banchereau, J., Bazan, F., Blanchard, D., Briere, E, Galizzi, J.P., van Kooten, C., Liu, Y.J., Rousset, F. and Saeland, S. (1994) "The CD40 antigen and its ligand", Annu. Rev. ImmunoL 12, 881–922.
   PubMed Web of Science ®Google Scholar
• Foy, TM., Aruffo, A., Bajorath, J., Buhlmann, J.E. and Noelle, R.J. (1996) "Immune regulation by CD40 and its ligand GP39", Annu. Rev. Immunol. 14, 591–617.
   PubMed Web of Science ®Google Scholar
• Carayanniotis, G., Masters, S.R. and Noelle, R.J. (1997) "Suppression of murine thyroiditis via blockade of the CD40 — CD4OL interaction", Immunology 90, 421–426.
   PubMed Web of Science ®Google Scholar
• Tomer, Y, Concepcion, E. and Greenberg, D.A. (2002) "A C/T single nucleotide polymorphism in the region of the CD40 gene is associated with Graves' disease", Thyroid 12, 1129–1135.
   PubMed Web of Science ®Google Scholar
• Demaine, A., Welsh, K.I., Hawe, B.S. and Farid, N.R. (1987) "Polymorphism of the T cell receptor beta-chain in Graves' disease", J. Clin. Endocrinol. Metab. 65, 643–646.
   PubMed Web of Science ®Google Scholar
• Weetman, A.P., So, AK., Roe, C., Walport, M.J. and Foroni, L. (1987) "T-cell receptor alpha chain V region polymorphism linked to primary autoimmune hypothyroidism but not Graves' disease", Hum. ImmunoL 20, 167–173.
   PubMed Web of Science ®Google Scholar
• Roman, S.H., Hubbard, M. and Rubinstein, P. "Failure to confirm standard HLA and Gm immunogenetic typing as a predictor of familial autoimmune thyroid disease". The 74th Annual Meeting of the Endocrine Society, Seattle, WA, June 1989.
   Google Scholar
• Falchfakh, F., Maalej, A., Makni, H., Abid, M., Jouida, J., Zouali, M. and Ayadi, H. (1999) "Analysis of immunoglobulin VH and TCR cbeta polymorphisms in a large family with thyroid autoimmune disorder", Exp. Clin. Immunogenet. 16, 185–191.
   PubMedGoogle Scholar
• Blakemore, A.I.F., Watson, P.F., Weetman, A.P. and Duff, G.W. (1995) "Association of Graves' disease with an allele of the interleukin-1 receptor antagonist gene", J. ClM. Endocrinol. Metab. 80, 111–115.
   PubMed Web of Science ®Google Scholar
• Cuddihy, R.M. and Bahn, R.S. (1996) "Lack of an association between alleles of interleukin-1 alpha and interleukin-1 receptor antagonist genes and Graves' disease in a north American Caucasian population", J. aim Endocrinol. Metab. 81, 4476–4478.
   PubMed Web of Science ®Google Scholar
• Muhlberg, T., Kirchberger, M., Spitzweg, C., Herrmann, F., Heberling, H.J. and Heufelder, A.E. (1998) "Lack of association of Graves' disease with the A2 allele of the interleukin-1 receptor antagonist gene in a white European population", Eur. J. Endocrinol. 138, 686–690.
   PubMed Web of Science ®Google Scholar
• Heward, J., Allahabadia, A., Gordon, C., Sheppard, MC., Barnett, A.H., Franklyn, J.A. and Gough, S.C. (1999) "The interleukin-1 receptor antagonist gene shows no allelic association with three autoimmune diseases", Thyroid 9, 627–628.
   PubMed Web of Science ®Google Scholar
• Siegmund, T., Usadel, K.H., Donner, H., Braun, J., Walfish, PG. and Badenhoop, K. (1998) "Interferon-gamma gene microsatellite pollymorphisms in patients with Graves' disease", Thyroid 8, 1013–1017.
   PubMed Web of Science ®Google Scholar
• Rau, H., Nicolay, A., Usadel, K.H., Finke, R., Donner, H., Walfish, PG. and Badenhoop, K. (1997) "Polymorphisms of TAP1 and TAP2 genes in Graves' disease", Tissue Antigens 49, 16–22.
   PubMedGoogle Scholar
• Heward, J.M., Nithiyananthan, R., Allahabadia, A., Gibson, S., Franklyn, J.A. and Gough, S.C. (2001) "No association of an interleukin 4 gene promoter polymorphism with Graves' disease in the United Kingdom", J. Clin. Endocrinol. Metab. 86, 3861–3863.
   PubMed Web of Science ®Google Scholar
• Pani, MA., Regulla, K., Segni, M., Hofmann, S., Hufner, M., Pasquino, A.M., Usadel, K.H. and Badenhoop, K. (2002) "A polymorphism within the vitamin D-binding protein gene is associated with Graves' disease but not with Hashimoto's thyroiditis", J. Clin. Endocrinol. Metab. 87, 2564–2567.
   PubMed Web of Science ®Google Scholar
• Tomer, Y, Greenberg, D.A., Concepcion, E., Ban, Y. and Davies, T.F. (2002) "Thyroglobulin is a thyroid specific gene for the familial autoimmune thyroid diseases", J. aim Endocrinol. Metab. 87, 404–407.
   PubMed Web of Science ®Google Scholar
• Sakai, K., Shirasawa, S., Ishikawa, N., Ito, K., Tamai, H., Kuma, K., Akamizu, T., Tanimura, M., Furugaki, K., Yamamoto, K. and Sasazuki, T. (2001) "Identification of susceptibility loci for autoimmune thyroid disease to 5q31-q33 and Hashimoto's thyroiditis to 8q23-q24 by multipoint affected sib-pair linkage analysis in Japanese", Hum. Mol. Genet. 10, 1379–1386.
   PubMed Web of Science ®Google Scholar
• Tonacchera, M. and Pinchera, A. (2000) "Thyrotropin receptor polymorphisms and thyroid diseases", J. Clin. Endocrinol. Metab. 85, 2637–2639.
   PubMed Web of Science ®Google Scholar
• Cuddihy, R.M., Dutton, C.M. and Bahn, R.S. (1995) "A polymorphism in the extracellular domain of the thyrotropin receptor is highly associated with autoimmune thyroid disease in females", Thyroid 5, 89–95.
   PubMed Web of Science ®Google Scholar
• Kotsa, K.D., Watson, P.F. and Weetman, A.P. (1997) "No association between a thyrotropin receptor gene polymor-phism and Graves' disease in the female population", Thyroid 7, 31 —33.
   Web of Science ®Google Scholar
• Allahabadia, A., Heward, J.M., Mijovic, C., Carr-Smith, J., Daykin, J., Cockram, C., Barnett, A.H., Sheppard, M.C., Franklyn, J.A. and Gough, S.C. (1998) "Lack of association between polymorphism of the thyrotropin receptor gene and Graves' disease in United Kingdom and Hong Kong Chinese patients: case control and family-based studies", Thyroid 8, 777–780.
   PubMed Web of Science ®Google Scholar
• Simanainen, J., Kinch, A., Westermark, K., Winsa, B., Bengtsson, M., Schuppert, F., Westermark, B. and Heldin, N.E. (1999) "Analysis of mutations in exon 1 of the human thyrotropin receptor gene: high frequency of the D36H and P52T polymorphic variants", Thyroid 9, 7–11.
   PubMed Web of Science ®Google Scholar
• Kaczur, V., Takacs, M., Szalai, C., Falus, A., Nagy, Z., Berencsi, G. and Balazs, C. (2000) "Analysis of the genetic variability of the 1st (CCC/ACC, P52T) and the 10th exons (bp 1012-1704) of the TSH receptor gene in Graves' disease", Eur. J. Immunogenet. 27, 17–23.
   PubMedGoogle Scholar
• Chistyakov, D.A., Savost'anov, K.V., Turakulov, RI., Petunina, NA., Trukhina, L.V., Kudinova, A.V., Balabolkin, M.I. and Nosikov, V.V. (2000) "Complex association analysis of graves disease using a set of polymorphic markers", MoL Genet. Metab. 70, 214–218.
   Google Scholar
• Rapoport, B., Chazenbalk, G.D., Jaume, J.C. and McLachlan, S.M. (1998) "The thyrotropin (TSH) receptor: interaction with TSH and autoantibodies", Endocr. Rev. 19, 673–716.
   PubMed Web of Science ®Google Scholar
• Tomer, Y, Barbesino, G., Greenberg, D.A., Concepcion, ES. and Davies, T.F. (1999) "Mapping the major susceptibility loci for familial Graves' and Hashimoto's diseases: Evidence for genetic heterogeneity and gene interactions", J. Clin. Endocrinol. Metab. 84, 4656–4664.
   PubMed Web of Science ®Google Scholar
• De Roux, N., Shields, D.C., Misrahi, M., Ratanachaiyavong, S., McGregor, AM. and Milgrom, E. (1996) "Analysis of the thyrotropin receptor as a candidate gene in familial Graves' disease", J. Clin. Endocrinol. Metab. 81, 3483–3486.
   PubMed Web of Science ®Google Scholar
• Chistiakov, D.A., Savost'anov, K.V., Turakulov, RI., Petunina, N., Balabolkin, M.I. and Nosikov, V.V. (2002) "Further studies of genetic susceptibility to Graves' disease in a Russian population", Med. Sci. Monit. 8, CR180—CR184.
   Google Scholar
• Muhlberg, T., Herrmann, K., Joba, W., Kirchberger, M., Heberling, H.J. and Heufelder, A.E. (2000) "Lack of association of nonautoimmune hyperfunctioning thyroid disorders and a germ-line polymorphism of codon 727 of the human thyrotropin receptor in a European Caucasian population", J. Clin. Endocrinol. Metab. 85, 2640–2643.
   PubMed Web of Science ®Google Scholar
• Ban, Y., Greenberg, D.A., Concepcion, ES. and Tomer, Y. (2002) "A germline single nucleotide polymorphism at the intracellular domain of the human thyrotropin receptor does not have a major effect on the development of Graves' disease", Thyroid 12, 1079–1083.
   PubMed Web of Science ®Google Scholar
• Pirro, MT., De Filippis, V., Di Cerbo, A., Scillitani, A., Liuzzi, A. and Tassi, V. (1995) "Thyroperoxidase microsatellite poly-morphism in thyroid disease", Thyroid 5, 461–464.
   PubMed Web of Science ®Google Scholar
• Tomer, Y, Barbesino, G., Keddache, M., Greenberg, DA. and Davies, T.F. (1997) "Mapping of a major susceptibility locus for Graves' disease (GD-1) to chromosome 14q31", J. Clin. Endocrinol. Metab. 82, 1645–1648.
   PubMed Web of Science ®Google Scholar
• Kawa, A., Nakamura, S., Nakazawa, M., Sakaguch, S., Kawabata, T., Maeda, Y. and Kanehisa, T. (1977) "HLA-BW35 and B5 in Japanese patients with Graves' disease", Acta Endocrinol. (Copenh.) 86, 754–757.
   PubMedGoogle Scholar
• Inoue, D., Sato, K., Enomoto, T., Sugawa, H., Maeda, M., Inoko, H., Tsuji, K., Mori, T. and Imura, H. (1992) "Correlation of HLA types and clinical findings in Japanese patients with hyperthyroid Graves' disease: evidence indicating the existence of four subpopulations", Gun. Endocrinol. (Oxf.) 36, 75–82.
   PubMed Web of Science ®Google Scholar
• Onuma, H., Ota, M., Sugenoya, A. and Inoko, H. (1994) "Association of HLA-DPB1*0501 with early-onset Graves' disease in Japanese", Hum. Immunol. 39, 195–201.
   PubMed Web of Science ®Google Scholar
• Katsuren, E., Awata, T., Matsumoto, C. and Yamamoto, K. (1994) "HLA class II alleles in Japanese patients with Graves' disease: weak associations of HLA-DR and -DQ", Endocr. J. 41, 599–603.
   PubMed Web of Science ®Google Scholar
• Ohtsuka, K. and Nakamura, Y. (1998) "Human leukocyte antigens associated with hyperthyroid Graves ophthalmology in Japanese patients", Am. J. OphthalmoL 126, 805–810.
   PubMed Web of Science ®Google Scholar
• Chan, S.H., Yeo, RP., Lui, K.F., Wee, GB., Woo, K.T., Lim, P. and Cheah, J.S. (1978) "HLA and thyrotoxicosis (Graves' disease) in Chinese", Tissue Antigens 12, 109–114.
   PubMedGoogle Scholar
• Cavan, D.A., Penny, MA., Jacobs, KR, Kelly, MA., Jenkins, D., Mijovic, C., Chow, C., Cockram, CS., Hawkins, B.R. and Barnett, AR (1994) "The HLA association with Graves' disease is sex-specific in Hong Kong Chinese subjects", Clin. Endocrinol. (Oxf.) 40, 63–66.
   PubMed Web of Science ®Google Scholar
• Chan, S.H., Lin, Y.N., Wee, GB., Ren, E.C., Lui, K.F. and Cheah, J.S. (1993) "Human leucocyte antigen DNA typing in Singaporean Chinese patients with Graves' disease", Ann. Acad. Med. Singapore 22, 576–579.
   PubMedGoogle Scholar
• Tan, S., Chan, S., Lee, B., Wee, G. and Wong, H. (1988) "HLA association in Singapore children with Grave's disease", Metabolism 37, 518–519.
   PubMed Web of Science ®Google Scholar
• Yeo, RP., Chan, S.H., Thai, AC., Ng, WY, Lui, K.F., Wee, GB., Tan, S.H., Lee, B.W., Wong, H.B. and Cheah, J.S. (1989) "HLA Bw46 and DR9 associations in Graves' disease of Chinese patients are age- and sex-related", Tissue Antigens 34, 179–184.
   PubMedGoogle Scholar
• Chen, Q.Y., Nadell, D., Zhang, X.Y., Kukreja, A., Huang, Y.J., Wise, J., Svec, F., Richards, R., Friday, K.E., Vargas, A., Gomez, R., Chalew, S., Lan, US., Tomer, Y. and Maclaren, N.K. (2000) "The human leukocyte antigen HLA DRB3*020/DQA1*0501 haplotype is associated with Graves' disease in African Americans", J. Clin. Endocrinol. Metab. 85, 1545–1549.
   PubMed Web of Science ®Google Scholar
• Maciel, L.M., Rodrigues, S.S., Dibbern, R.S., Navarro, PA. and Donadi, E.A. (2001) "Association of the HLA-DRB1*0301 and HLA-DQA1*0501 alleles with Graves' disease in a population representing the gene contribution from several ethnic back-grounds", Thyroid 11, 31–35.
   PubMed Web of Science ®Google Scholar
• Honda, K., Tamai, H., Morita, T., Kuma, K., Nishimura, Y. and Sasazuki, T. (1989) "Hashimoto's thyroiditis and HLA in Japanese", J. Clin. Endocrinol. Metab. 69, 1268–1273.
   PubMed Web of Science ®Google Scholar
• Hawkins, BR., Lam, K.S.L., Ma, J.T.C., Wang, C. and Yeung, R.T.T. (1987) "Strong association between HLA-DRw9 and Hashimoto's thyroiditis in Southern Chinese", Acta Endocrinol. 114, 543–546.
   PubMedGoogle Scholar
• Hawkins, BR., Ma, J.T., Lam, KS., Wang, C.C. and Yeung, R.T. (1985) "Analysis of linkage between HLA haplotype and susceptibility to Graves' disease in multiple-case Chinese families in Hong Kong", Acta Endocrinol. (Copenh.) 110, 66–69.
   PubMedGoogle Scholar
• Akamizu, T., Sale, MM., Rich, S.S., Hiratani, H., Noh, J.Y., Kanamoto, N., Saijo, M., Miyamoto, Y, Saito, Y., Nakao, K. and Bowden, D.W. (2000) "Association of autoimmune thyroid disease with microsatellite markers for the thyrotropin receptor gene and CTLA-4 in Japanese patients", Thyroid 10, 851–858.
   PubMed Web of Science ®Google Scholar
• Kinjo, Y., Takasu, N., Komiya, I., Tomoyose, T., Takara, M., Kould, T., Shimajiri, Y, Yabiku, K. and Yoshimura, H. (2002) "Remission of Graves' hyperthyroidism and A/G polymorphism at position 49 in exon 1 of cytotoxic T lymphocyte-associated molecule-4 gene", J. Clin. Endocrinol. Metab. 87, 2593–2596.
   PubMed Web of Science ®Google Scholar
• Sale, maw, Akamizu, T., Howard, T.D., Yokota, T., Nakao, K., Mori, T., Iwasaki, H., Rich, S.S., Jennings-Gee, J.E., Yamada, M. and Bowden, D.W. (1997) "Association of autoimmune thyroid disease with a microsatellite marker for the thyrotropin receptor gene and CTLA-4 in a Japanese population", Proc. Assoc. Am. Physicians 109, 453–461.
   PubMedGoogle Scholar
• Nagatald, S. (1986) "The interaction of MHC and Gm in liability to autoimmune thyroid disease", Mol. Biol. Med. 3, 73–84.
   PubMedGoogle Scholar
• Nakao, Y, Matsumoto, H., Miyazaki, T., Nishitani, H., Takatsuki, K., Kasukawa, R., Nakayama, S., Izumi, S., Fujita, T. and Tsuji, K. (1980) "IgG heavy chain allotypes (Gm) in atrophic and goitrous thyroiditis", Clin. Exp. Immunol. 42, 20–26.
   PubMed Web of Science ®Google Scholar
• Kamizono, S., Hiromatsu, Y., Seki, N., Bednarczuk, T., Matsumoto, H., Kimura, A. and Itoh, K. (2000) "A polymorphism of the 5' flanking region of tumour necrosis factor alpha gene is associated with thyroid-associated ophthalmopathy in Japanese", Clin. Endocrinol. (Oxf.) 52, 759–764.
   Web of Science ®Google Scholar
• Ban, Y, Taniyama, M. and Ban, Y. (2000) "Vitamin D receptor gene polymorphism is associated with Graves' disease in the Japanese population", J. Clin. Endocrinol. Metab. 85, 4639–4643.
   PubMed Web of Science ®Google Scholar
• Yamazaki, K., Takazoe, M., Tanaka, T., Kazumori, T. and Nakamura, Y. (2002) "Absence of mutation in the NOD2/CARD15 gene among 483 Japanese patients with Crohn's disease", J. Hum. Genet. 47, 469–472.
   PubMed Web of Science ®Google Scholar
• Buus, S., Sette, A. and Grey, H.M. (1987) "The interaction between protein-derived immunogenic peptides and, la", Immunol Rev. 98, 115–141.
   PubMed Web of Science ®Google Scholar
• Nelson, J.L. and Hansen, J.A. (1990) "Autoimmune disease and HLA", CRC Grit. Rev. Immunol. 10, 307–328.
   PubMed Web of Science ®Google Scholar
• Foos, S. and Trucco, M. (1994) "The genes influencing the susceptibility to 1DDM in humans", J. Endocrinol. Investig. 17, 477–495.
   PubMed Web of Science ®Google Scholar
• Aitman, T.J. and Todd, J.A. (1995) "Molecular genetics of diabetes mellitus", Bailliere's Clin. Endocrinol. Metab. 9, 63 1— 656.
   Google Scholar
• Morel, PA., Dorman, J.S., Todd, J.A., McDevitt, HO. and Trucco, M. (1988) "Aspartic acid at position 57 of the HLA-DQ beta-chain protects against type I diabetes: a family study", Proc. Natl Acad. Sci. USA 85, 8111–8115.
   PubMed Web of Science ®Google Scholar
• Brown, J.H., Jardetzky, T., Gorga,Stern, L.J., Urban, R.G.,Strominger, J.L. and Wiley, D.C. (1993) "Three-dimensional structure of the human class II histocompatibility antigen HLA-DR1", Nature 364, 33–39.
   PubMed Web of Science ®Google Scholar
• Lee, K.H., Wucherpfennig, K.W. and Wiley, D.C. (2001) "Structure of a human insulin peptide-HLA-DQ8 complex and susceptibility to type 1 diabetes", Nat. Immunol. 2, 501–507.
   PubMed Web of Science ®Google Scholar
• Wucherpfennig, K.W. (2001) "Insights into autoimmunity gained from structural analysis of MHC-peptide complexes", Curr. Opin. Immunol. 13, 650–656.
   PubMed Web of Science ®Google Scholar
• Sawai, Y. and DeGroot, L.J. (2000) "Binding of human thyrotropin receptor peptides to a Graves' disease-predisposing human leukocyte antigen class II molecule", J. Clin. Endocrinol. Metab. 85, 1176–1179.
   PubMed Web of Science ®Google Scholar
• Hanafusa, T., Pujol Borrell, R., Chiovato, L., Russell, R.C., Doniach, D. and Bottazzo, G.F (1983) "Aberrant expression of HLA-DR antigen on thyrocytes in Graves' disease: relevance for autoimmunity", Lancet 2, 1111–1115.
   PubMed Web of Science ®Google Scholar
• Bottazzo, G.F., Pujol Borrell, R., Hanafusa, T. and Feldmann, M. (1983) "Role of aberrant HLA-DR expression and antigen presentation in induction of endocrine autoimmunity", Lancet 2, U 15–1119.
   Google Scholar
• Davies, T.F. (1985) "Cocultures of huan thyroid monolayer cells and autologous T cells: impact of HLA class II antigen expression", J. Clin. Endocrinol. Metab. 61, 418–422.
   PubMed Web of Science ®Google Scholar
• Londei, M., Lamb, J.R., Bottazzo, G.F. and Feldmann, M. (1984) "Epithelial cells expressing aberrant MHC class II determinants can present antigen to cloned human T cells", Nature 312, 639–641.
   PubMed Web of Science ®Google Scholar
• Davies, T.F. and Piccinini, L.A. (1987) "Intrathyroidal MHC class II antigen expression and thyroid autoimmunity", Endocrinol. Metab. Clin. North Am. 16, 247–268.
   PubMed Web of Science ®Google Scholar
• Neufeld, D.S., Platzer, M. and Davies, T.F. (1989) "Reovirus induction of MHC class II antigen in rat thyroid cells", Endocrinology 124, 543–545.
   PubMed Web of Science ®Google Scholar
• Belfiore, A., Mauerhoff, T., Pujol Borrell, R., Badenhoop, K., Buscema, M., Mirakian, R. and Bottazzo, G.F. (1991) "De novo HLA class II and enhanced HLA class I molecule expression in SV40 transfected human thyroid epithelial cells", J. Autoimmun. 4, 397–414.
   PubMed Web of Science ®Google Scholar
• Shimojo, N., Kohno, Y, Yamaguchi, K., Kikuoka, S., Hoshioka, A., Niimi, H., Hirai, A., Tamura, Y, Saito, Y, Kohn, L.D. and Tahara, K. (1996) "Induction of Graves-like disease in mice by immunization with fibroblasts transfected with the thyrotropin receptor and a class 11 molecule", Proc. Natl Acad. Sci. USA 93, 11074–11079.
   PubMed Web of Science ®Google Scholar
• Kita, M., Ahmad, L., Marians, R.C., Vlase, H., Unger, P., Graves, RN. and Davies, T.F. (1999) "Regulation and transfer of a murine model of thyrotropin receptor antibody mediated Graves' disease", Endocrinology 140, 1392–1398.
   PubMed Web of Science ®Google Scholar
• Davies, T.F., Bermas, B., Platzer, M. and Roman, S.H. (1985) "T-cell sensitization to autologous thyroid cells and normal non-specific suppressor T-cell function in Graves' disease", Clin. Endocrinol. (Oxf ) 22, 155–167.
   PubMed Web of Science ®Google Scholar
• Eguchi, K., Otsubo, T., Kawabe, K., Ueki, Y, Fukuda, T., Mayumi, M., Shimomura, C., Ishikawa, N., Nakao, H., Ito, K., Morimoto, C. and Nagataki, S. (1987) "The remarkable proliferation of helper T cell subset in response to autologous thyrocytes and intrathyroidal T cells from patients with Graves' disease", Isr. J. Med. Sci. 70, 403–410.
   Google Scholar
• Migita, K., Eguchi, K., Otsubo, T., Kawakami, A., Nakao, H., Ueki, Y, Shimomura, C., Kurata, A., Fukuda, T., Matsunaga, M., et al. (1990) "Cytokine regulation of HLA on thyroid epithelial cells", Clin. Exp. Immunol. 82, 548–552.
   PubMed Web of Science ®Google Scholar
• Weetman, A.P. and McGregor, A.M. (1994) "Autoimmune thyroid disease: further developments in our understanding", Endocr Rev. 15, 788 — 830.
   PubMed Web of Science ®Google Scholar
• Kould, T., Sawai, Y, Gardine, CA., Fisfalen, ME., Alegre, M.L. and DeGroot, L.J. (2000) "CTLA-4 gene polymorphism at position 49 in exon 1 reduces the inhibitory function of CTLA-4 and contributes to the pathogenesis of Graves' disease", J. Immunol. 165, 6606–6611.
   PubMed Web of Science ®Google Scholar
• Xu, Y, Graves, P., Tomer, Y. and Davies, T. (2002) "CTLA-4 and autoimmune thyroid disease: lack of influence of the A49G signal peptide polymorphism on functional recombinant human CTLA-4", Cell Immunol. 215, 133.
   PubMed Web of Science ®Google Scholar
• Huang, D., Giscombe, R., Zhou, Y, Pirskanen, R. and Lefvert, A.K. (2000) "Dinucleotide repeat expansion in the CTLA-4 gene leads to T cell hyper-reactivity via the CD28 pathway in myasthenia gravis", J. Neuroimmunol. 105, 69–77.
   PubMed Web of Science ®Google Scholar
• Holopainen, P.M. and Partanen, J. (2001) "Technical note: linkage disequilibrium and disease-associated CTLA-4 gene polymorph-isms", J. Immunol. 167, 2457–2458.
   PubMed Web of Science ®Google Scholar
• Ban, Y, Greenberg, D.A., Concepcion, ES., Villanueva, R. and Tomer, Y "Amino acid substitutions in the thyroglobulin gene confer susceptibility to autoimmune thyroid disease". The 85th Annual Meeting of the Endocrine Society, Philadelphia, PA, June 2003.
   Google Scholar
• Bagchi, N., Brown, T.R., Urdanivia, E. and Sundick, R.S. (1985) "Induction of autoimmune thyroiditis in chickens by dietary iodine", Science 230, 325–327.
   PubMed Web of Science ®Google Scholar
• Kahaly, G.J., Dienes, H.P., Beyer, J. and Hommel, G. (1998) "Iodide induces thyroid autoimmunity in patients with endemic goitre: a randomised, double-blind, placebo-controlled trial", Eur J. Endocrinol. 139, 290–297.
   PubMed Web of Science ®Google Scholar
• Papanastasiou, L, Alevizaki, M., Piperingos, G., Mantzos, E., Tseleni-Balafouta, S. and Koutras, D.A. (2000) "The effect of iodine administration on the development of thyroid autoimmunity in patients with nontoxic goiter", Thyroid 10, 493–497.
   PubMed Web of Science ®Google Scholar
• Kong, Y.C., McCormick, D.J., Wan, Q., Motte, R.W., Fuller, BE., Giraldo, A.A. and David, C.S. (1995) "Primary hormonogenic sites as conserved autoepitopes on thyroglobulin in murine autoimmune thyroiditis. Secondary role of iodination", J. Immunol. 155, 5847–5854.
   PubMed Web of Science ®Google Scholar
• Hutchings, P.R., Cooke, A., Dawe, K., Champion, BR., Geysen, M., Valerio, R. and Roitt, I.M. (1992) "A thyroxine-containing peptide can induce murine experimental autoimmune thyroiditis", J. Exp. Med. 175, 869–872.
   PubMed Web of Science ®Google Scholar
• Stenszky, V., Kozma, L., Balazs, C., Rochldtz, S., Bear, J.C. and Farid, N.R. (1985) "The genetics of Graves' disease: HLA and disease susceptibility", J. Clin. Endocrinol. Metab. 61, 735–740.
   PubMed Web of Science ®Google Scholar
• Weetman, AR, So, AK., Warner, CA., Foroni, L., Fells, P. and Shine, B. (1988) "Immunogenetics of Graves' ophthalmopathy", Clin. Endocrinol. 28, 619–628.
   PubMed Web of Science ®Google Scholar
• Chen, Q.Y., Huang, W., She, J.X., Baxter, F., Volpe, R. and Maclaren, N.K. (1999) "HLA-DRB1*08, DRB1*03/DRB3*0101, and DRB3*0202 are susceptibility genes for Graves' disease in North American Caucasians, whereas DRB1*07 is protective", J. Clin. Endocrinol. Metab. 84, 3182–3186.
   PubMed Web of Science ®Google Scholar
• Hawkins, BR., Ma, IT., Lam, KS., Wang, C.C. and Yeung, R.T. (1985) "Association of HLA antigens with thyrotoxic Graves' disease and periodic paralysis in Hong Kong Chinese", Clin. Endocrinol. (Oxf ) 23, 245–252.
   PubMed Web of Science ®Google Scholar
• Dong, R.P., Kimura, A., Okubo, R., Shinagawa, H., Tamai, H., Nishimura, Y. and Sasazuld, T. (1992) "HLA-A and DPB1 loci confer susceptibility to Graves' disease", Hum. Immunol. 35, 165–172.
   PubMed Web of Science ®Google Scholar
• Cho, BY., Rhee, B.D., Lee, D.S., Lee, US., Kim, G.Y., Lee, H.K., Koh, CS., Min, H.K. and Lee, M. (1987) "HLA and Graves' disease in Koreans", Tissue Antigens 30, 119–121.
   PubMedGoogle Scholar
• Tandon, N., Mehra, N.K., Taneja, V., Vaidya, M.C. and Kochupillai, N. (1990) "HLA antigens in Asian Indian patients with Graves' disease", Clin. Endocrinol. (Oxf) 33, 21–26.
   PubMed Web of Science ®Google Scholar
• Sridama, V., Hara, Y, Fauchet, R. and DeGroot, L.J. (1987) "HLA inununogentic heterogenity in black American patients with Graves' disease", Arch. Intern. Med. 147, 229–231.
   PubMedGoogle Scholar
• Chen, Q.Y., Nadell, D., Zhang, X.Y., Kulcreja, A., Huang, Y.J., Wise, J., Svec, F., Richards, R., Friday, K.E., Vargas, A., Gomez, R., Chalew, S., Lan, M.S., Tomer, Y. and Maclaren, N.K. (2000) "The human leukocyte antigen HLA DRB3*020/DQA1*0501 haplotype is associated with Graves' disease in African Americans", J. Clin. Endocrinol. Metab. 85, 1545–1549.
   PubMed Web of Science ®Google Scholar
• Omar, MA., Hammond, M.G., Desai, R.K., Motala, A.A., Aboo, N. and Seedat, M.A. (1990) "HLA class I and 11 antigens in South African blacks with Graves' disease", Clin. Immunol. ImmunopathoL 54, 98–102.
   PubMedGoogle Scholar